CVKD
Cadrenal Therapeutics, Inc. Common Stock
NASDAQ: CVKD · HEALTHCARE · BIOTECHNOLOGY
$6.67
+19.32% today
Updated 2026-04-30
Market cap
$13.79M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-6.64
Dividend yield
—
52W range
$4 – $17
Volume
0.1M
Cadrenal Therapeutics, Inc. Common Stock (CVKD) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Operating cash flow | $-1.20M | $-3.53M | $-7.36M | $-12.60M |
| Capital expenditures | $2486.00 | $3254.00 | $6537.00 | $5104.00 |
| Depreciation | $1266.00 | $1980.00 | $1880.00 | — |
| Stock-based comp | — | $710381.00 | $1.42M | $1.94M |
| Free cash flow | $-1.21M | $-3.53M | $-7.36M | $-12.61M |
| Investing cash flow | $-2279.00 | $-3254.00 | $-6537.00 | — |
| Financing cash flow | $1.24M | $11.90M | $8.98M | — |
| Dividends paid | — | — | — | — |
| Share repurchases | — | — | — | — |
| Debt repayment | — | — | — | — |
| Net change in cash | — | — | — | — |